Sonja Mandl–Weber

1.1k citations

26 papers · 921 indexed · h-index 16

Impact in

Hematology top 5%
- Multiple Myeloma Research and Treatments
Nephrology top 5%
- Dialysis and Renal Disease Management

Papers in

Hematology 16
- Multiple Myeloma Research and Treatments 14
Nephrology 3
- Dialysis and Renal Disease Management 3

Co-authors: Ralf Schmidmaier Fuat Oduncu Philipp Baumann Bettina Haslinger Thomas Sitter Bertold Emmerich Clemens D. Cohen Matthias Kretzler
Journals: British Journal of Haematology (3 papers)Anti-Cancer Drugs (3 papers)Peritoneal Dialysis International (3 papers)Blood (3 papers)Molecular Cancer Therapeutics (2 papers)
Partner nations: Germany Netherlands Taiwan

In The Last Decade

Sonja Mandl–Weber

26 papers receiving 902 citations

Peers

Countries citing papers authored by Sonja Mandl–Weber

Since Specialization

Citations

This map shows the geographic impact of Sonja Mandl–Weber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sonja Mandl–Weber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sonja Mandl–Weber more than expected).

Fields of papers citing papers by Sonja Mandl–Weber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sonja Mandl–Weber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sonja Mandl–Weber. The network helps show where Sonja Mandl–Weber may publish in the future.

Co-authors

The 25 scholars most cited alongside Sonja Mandl–Weber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sonja Mandl–Weber Line = papers co-authored together Sonja Mandl–Weber links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Simultaneous targeting of PI3K and mTOR with NVP-BGT226 is highly effective in multiple myeloma Anti-Cancer Drugs ·Philipp Baumann, J. Novoa Fernandez, Sonja Mandl–Weber, Fuat Oduncu, Ralf Schmidmaier	2011	44
2	The pan‐histone deacetylase inhibitor CR2408 disrupts cell cycle progression, diminishes proliferation and causes apoptosis in multiple myeloma cells British Journal of Haematology ·Philipp Baumann, I.A. Merkul, Sonja Mandl–Weber, Stefan Strobl, Fuat Oduncu, Ralf Schmidmaier	2011	13
3	Peripheral T-cell Lymphoma With Progression to a Clonally Related, Epstein Barr Virus+, Cytotoxic Aggressive T-cell Lymphoma: Evidence for Secondary EBV Infection of an Established Malignant T-cell Clone The American Journal of Surgical Pathology ·Rupert Langer, Eva Geissinger, Thomas Rüdiger, Christoph von Schilling, German Ott, Sonja Mandl–Weber, Leticia Quintanilla-Martı́nez, Falko Fend	2010	11
4	The novel inhibitor of histone deacetylase resminostat (RAS2410) inhibits proliferation and induces apoptosis in multiple myeloma (MM) cells British Journal of Haematology ·Sonja Mandl–Weber, Felix G. Meinel, Strutt Nicholas, Fuat Oduncu, Ralf Schmidmaier, Philipp Baumann	2010	61
5	The peptide‐semicarbazone S‐2209, a representative of a new class of proteasome inhibitors, induces apoptosis and cell growth arrest in multiple myeloma cells British Journal of Haematology ·Philipp Baumann, Karin Müller, Sonja Mandl–Weber, Johann Leban, Carlos Alberto Velasco Díaz, B. M. Larsen, Roland Baumgartner, Fuat Oduncu, Ralf Schmidmaier	2009	13
6	Myeloma cell growth inhibition is augmented by synchronous inhibition of the insulin-like growth factor-1 receptor by NVP-AEW541 and inhibition of mammalian target of rapamycin by Rad001 Anti-Cancer Drugs ·Philipp Baumann, Rajesh Nasinathan, Sonja Mandl–Weber, Daniel Franke, Ralf Schmidmaier	2009	21
7	Alkylating agents induce activation of NFκB in multiple myeloma cells Leukemia Research ·Philipp Baumann, Sonja Mandl–Weber, Fuat Oduncu, Ralf Schmidmaier	2008	23
8	The novel orally bioavailable inhibitor of phosphoinositol-3-kinase and mammalian target of rapamycin, NVP-BEZ235, inhibits growth and proliferation in multiple myeloma Experimental Cell Research ·Philipp Baumann, Sonja Mandl–Weber, Fuat Oduncu, Ralf Schmidmaier	2008	101
9	Inhibitors of protein kinase C sensitise multiple myeloma cells to common genotoxic drugs European Journal Of Haematology ·Philipp Baumann, Jakob Armann, Sonja Mandl–Weber, Zhongming Zhao, Fuat Oduncu, Ralf Schmidmaier	2007	8
10	Activation of adenosine monophosphate activated protein kinase inhibits growth of multiple myeloma cells Experimental Cell Research ·Philipp Baumann, Sonja Mandl–Weber, Bertold Emmerich, Christian Straka, Ralf Schmidmaier	2007	44
11	Bendamustine induces G2 cell cycle arrest and apoptosis in myeloma cells: the role of ATM-Chk2-Cdc25A and ATM-p53-p21-pathways Journal of Cancer Research and Clinical Oncology ·Tsai-Chung Weng, Sonja Mandl–Weber, Philipp Baumann, Bertold Emmerich, Ralf Schmidmaier	2007	56
12	Inhibition of adenosine monophosphate-activated protein kinase induces apoptosis in multiple myeloma cells Anti-Cancer Drugs ·Philipp Baumann, Sonja Mandl–Weber, Bertold Emmerich, Christian Straka, Ralf Schmidmaier	2007	34
13	Inhibition of lymphocyte function associated antigen 1 by LFA878 induces apoptosis in multiple myeloma cells and is associated with downregulation of the focal adhesion kinase/phosphatidylinositol 3 kinase/Akt pathway International Journal of Oncology ·Ralf Schmidmaier, Sonja Mandl–Weber, Tsai-Chung Weng, Philipp Baumann, Irmgard Bumeder, Christian Straka, Bertold Emmerich	2007	14
14	Discordant Bone Marrow Involvement in Diffuse Large B-Cell Lymphoma: Comparative Molecular Analysis Reveals a Heterogeneous Group of Disorders Laboratory Investigation ·Marcus Kremer, Martin S. Spitzer, Sonja Mandl–Weber, Gunilla Enhorning, Burkhard Schmidt, Heinz Höfler, Leticia Quintanilla-Martı́nez, Falko Fend	2003	41
15	Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells Kidney International ·Sonja Mandl–Weber, Clemens D. Cohen, Bettina Haslinger, Matthias Kretzler, Thomas Sitter	2002	113
16	Effect of High Glucose Concentration on the Synthesis of Monocyte Chemoattractant Protein-1 in Human Peritoneal Mesothelial Cells: Involvement of Protein Kinase C The Nephron journals/Nephron journals ·Bettina Haslinger, Sonja Mandl–Weber, Alois Sellmayer, Stephan R. Lederer, Thomas Sitter	2001	24
17	Hyaluronan fragments induce the synthesis of MCP-1 and IL-8 in cultured human peritoneal mesothelial cells Cell and Tissue Research ·Bettina Haslinger, Sonja Mandl–Weber, Alois Sellmayer, Thomas Sitter	2001	42
18	Heat-killed microorganisms induce PAI-1 expression in human peritoneal mesothelial cells: Role of interleukin-1α American Journal of Kidney Diseases ·Sonja Mandl–Weber, Bettina Haslinger, Stephan R. Lederer, Thomas Sitter	2001	11
19	Early Glycated Albumin, but Not Advanced Glycated Albumin, Methylglyoxal, or 3-Deoxyglucosone Increases the Expression of Pai-1 in Human Peritoneal Mesothelial Cells Peritoneal Dialysis International ·Sonja Mandl–Weber, Bettina Haslinger, Casper G. Schalkwijk, Thomas Sitter	2001	20
20	Thrombin Suppresses Matrix Metalloproteinase 2 Activity and Increases Tissue Inhibitor of Metalloproteinase 1 Synthesis in Cultured Human Peritoneal Mesothelial Cells Peritoneal Dialysis International ·Bettina Haslinger, Sonja Mandl–Weber, Thomas Sitter	2000	6

About Sonja Mandl–Weber

Sonja Mandl–Weber is a scholar working on Hematology, Nephrology, Pathology and Forensic Medicine, Molecular Biology and Genetics, having authored 26 papers that have together received 921 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (14 papers), Protein Kinase Regulation and GTPase Signaling (4 papers), Protein Degradation and Inhibitors (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Dialysis and Renal Disease Management (3 papers), Ubiquitin and proteasome pathways (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Intraperitoneal and Appendiceal Malignancies (2 papers). The work is most often cited by research in Hematology (241 citations), Nephrology (98 citations), Genetics (117 citations), Pathology and Forensic Medicine (153 citations) and Oncology (225 citations). Sonja Mandl–Weber has collaborated with scholars based in Germany, Netherlands and Taiwan. Frequent co-authors include Ralf Schmidmaier, Fuat Oduncu, Philipp Baumann, Bettina Haslinger, Thomas Sitter, Philipp Baumann, Bertold Emmerich, Clemens D. Cohen, Matthias Kretzler and Christian Straka. Their work appears in journals such as British Journal of Haematology, Anti-Cancer Drugs, Peritoneal Dialysis International, Blood and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact